Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H16N4O |
| Molecular Weight | 268.3137 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1N=C(C)C2=C1C(=NCC(=O)N2)C3=CC=CC=C3
InChI
InChIKey=YFHYNLHGFKXAIQ-UHFFFAOYSA-N
InChI=1S/C15H16N4O/c1-3-19-15-13(10(2)18-19)17-12(20)9-16-14(15)11-7-5-4-6-8-11/h4-8H,3,9H2,1-2H3,(H,17,20)
| Molecular Formula | C15H16N4O |
| Molecular Weight | 268.3137 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Ripazepam (CI 683 or pyrazapon) is a pyrazolodiazepine that has anxiolytic effects. It is related to certain benzodiazepines such as zolazepam. In animal studies, it showed anxiolytic effects without sedative or depressant effects. In rats, it did not elicit a tumorigenic potential. Although ripazepam was found significantly superior to placebo and was well tolerated in neurotic patients, it has never been marketed for clinical use.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:54:29 GMT 2025
by
admin
on
Mon Mar 31 17:54:29 GMT 2025
|
| Record UNII |
92000WH9C9
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1012
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB10328MIG
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
3751
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
CHEMBL159298
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
C009116
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
RIPAZEPAM
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
100000080569
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
C98140
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
92000WH9C9
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
DTXSID1021245
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
26308-28-1
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
2386
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY | |||
|
33474
Created by
admin on Mon Mar 31 17:54:29 GMT 2025 , Edited by admin on Mon Mar 31 17:54:29 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |